Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Dermoscopy is useful for diagnosing hair loss patterns in dogs.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Animal models are crucial for learning about hair loss and finding treatments.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Different scalp imaging methods are important for studying hair and scalp health and require more volunteers for better evaluation.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

TrichoScan effectively diagnoses different types of hair loss and is linked to low iron stores in patients.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

Mesotherapy is not significantly better than minoxidil for treating male hair loss.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

The hCG diet and testosterone therapy can cause hair loss in some people.

Women of child-bearing age with androgenic alopecia lose hair density, especially in certain areas, and their hair becomes thinner. They also lose more than twice as much hair as healthy women.

Low-level laser therapy is safe but not significantly better than minoxidil alone for hair growth.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Women with female pattern hair loss have lower Vitamin D3 levels.

Women with androgenetic alopecia have lower zinc and iron levels.